Daniel Von Hoff

Biography

Daniel Von Hoff, M.D. has devoted his career to translational medicine, which is defined as movement of new therapies from the research institution into patient care. He currently serves as the Executive Vice President, Senior Investigator and Head of Translational Research at the Translational Genomics Research Institute’s (TGen) Translational Drug Development Division and heads its Pancreatic Cancer Research Program. He is also Professor of Medicine, Molecular and Cellular Biology and Pathology at the University of Arizona and served as director of the Arizona Cancer Center. He also serves as Chief Scientific Officer for US Oncology and the Scottsdale Clinical Research Institute. In addition, he provides expertise as a founder or medical/scientific advisor to a broad range of companies working toward a cure for cancer. After graduating cum laude from Carroll College, Dr. Von Hoff received his M.D. from Columbia University College of Physicians and Surgeons. He completed his internship and residency in internal medicine at the University of California, San Francisco, then completed a medical oncology fellowship at the National Cancer Institute. Dr. Von Hoff then moved to the University of Texas Health Science Center at San Antonio, where he rose to Professor in the Department of Medicine and the Department of Cellular and Structural Biology

Research Interest

Daniel Von Hoff, M.D. has devoted his career to translational medicine, which is defined as movement of new therapies from the research institution into patient care. He currently serves as the Executive Vice President, Senior Investigator and Head of Translational Research at the Translational Genomics Research Institute’s (TGen) Translational Drug Development Division and heads its Pancreatic Cancer Research Program. He is also Professor of Medicine, Molecular and Cellular Biology and Pathology at the University of Arizona and served as director of the Arizona Cancer Center. He also serves as Chief Scientific Officer for US Oncology and the Scottsdale Clinical Research Institute. In addition, he provides expertise as a founder or medical/scientific advisor to a broad range of companies working toward a cure for cancer. After graduating cum laude from Carroll College, Dr. Von Hoff received his M.D. from Columbia University College of Physicians and Surgeons. He completed his internship and residency in internal medicine at the University of California, San Francisco, then completed a medical oncology fellowship at the National Cancer Institute. Dr. Von Hoff then moved to the University of Texas Health Science Center at San Antonio, where he rose to Professor in the Department of Medicine and the Department of Cellular and Structural Biology